Odyssey Health (ODYY) Profit After Tax Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -32.88% |
| Oct 31, 2025 | 7.44% |
| Jul 31, 2025 | 28.33% |
| Apr 30, 2025 | 24.10% |
| Jan 31, 2025 | 18.20% |
| Oct 31, 2024 | 6.38% |
| Jul 31, 2024 | 11.29% |
| Apr 30, 2024 | -68.09% |
| Jan 31, 2024 | 163.37% |
| Oct 31, 2023 | -50.58% |
| Jul 31, 2023 | -52.44% |
| Apr 30, 2023 | -77.17% |
| Jan 31, 2023 | -46.56% |
| Oct 31, 2022 | -102.32% |
| Jul 31, 2022 | -98.68% |
| Apr 30, 2022 | -107.79% |
| Jan 31, 2022 | -122.31% |
| Oct 31, 2021 | -137.32% |
| Jul 31, 2021 | -139.47% |
| Apr 30, 2021 | -332.62% |
| Jan 31, 2021 | -122.05% |
| Oct 31, 2020 | -95.38% |
| Jul 31, 2020 | -123.18% |
| Apr 30, 2020 | -88.05% |
| Jan 31, 2020 | -63.99% |
| Oct 31, 2019 | -100.72% |